Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.

İÇLİ F., AKBULUT H., DİNÇOL D., ONUR H., DEMİRKAZIK A., ÇAM R., ...Daha Fazla

Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, 15 Temmuz 2005

  • Yayın Türü: Bildiri / Özet Bildiri
  • Gazi Üniversitesi Adresli: Evet